Alector, Inc.·4

Aug 11, 6:23 PM ET

Paul Robert 4

4 · Alector, Inc. · Filed Aug 11, 2021

Insider Transaction Report

Form 4
Period: 2021-08-09
Paul Robert
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-08-09$8.16/sh+9,691$79,079244,010 total
  • Exercise/Conversion

    Common Stock

    2021-08-09$17.15/sh+4,525$77,604257,269 total
  • Sale

    Common Stock

    2021-08-09$27.17/sh22,650$615,430234,619 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-08-099,69181,000 total
    Exercise: $8.16Exp: 2028-07-02Common Stock (9,691 underlying)
  • Exercise/Conversion

    Common Stock

    2021-08-09$10.14/sh+8,734$88,563252,744 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-08-098,73431,250 total
    Exercise: $10.14Exp: 2028-11-06Common Stock (8,734 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-08-094,52584,450 total
    Exercise: $17.15Exp: 2029-11-06Common Stock (4,525 underlying)
  • Sale

    Common Stock

    2021-08-09$27.79/sh300$8,337234,319 total
Footnotes (6)
  • [F1]The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive.
  • [F4]Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018.
  • [F5]One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter.
  • [F6]Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION